Notification That Quarterly Report Will Be Submitted Late (nt 10-q)
November 15 2013 - 11:55AM
Edgar (US Regulatory)
U.S.
SECURITIES AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
12b-25
NOTIFICATION
OF LATE FILING
SEC
File Number: 000-1321002
☐
Form 10-K ☐ Form 20-F ☐ Form
11-K ☑ Form 10-Q ☐ Form
10-D ☐ Form N-SAR ☐ Form N-CSR
For period
ended: September 30, 2013
☐ Transition
Report on Form 10-K
☐ Transition
Report on Form 20-F
☐ Transition
Report on Form 11-K
☐ Transition
Report on Form 10-Q
☐ Transition
Report on Form N-SAR
For
the Transition Period Ended: N/A
|
Nothing in this form shall be construed to imply that the Commission has verified any information contained herein
.
|
|
PART
I
B
REGISTRANT INFORMATION
Mediswipe, Inc.
|
Full Name of Registrant:
|
|
407 E Fort Street, Suite 510
|
Address of Principal Executive Office
|
|
Detroit, MI. 48226
|
City, State and Zip Code
|
PART
II B RULES 12b-25 (b) AND (c)
If
the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule
12b-25(b), the following should be completed.
☑
|
(a)
|
The
reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;
|
☑
|
(b)
|
The
subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, 11-K or Form N-SAR or Form N-CSR, or
portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly
report or transition report on Form 10-Q, or portion thereof, will be filed on
or before the fifth calendar day following the prescribed due date; and
|
|
(c)
|
The
accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached, if applicable.
|
PART
III B NARRATIVE
The Company is unable to file its quarterly
report on Form 10-Q for the period ended September 30, 2013 within the prescribed time period due to its difficulty in completing
and obtaining required financial and other information without unreasonable effort and expense.
PART IV B OTHER INFORMATION
|
(1)
|
Name and telephone number of person to contact in regard to this notification
|
Barry Hollander
|
|
561
|
|
514-9042
|
(Name)
|
|
(Area Code)
|
|
(Telephone Number)
|
|
(2)
|
Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act
of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the
registrant was required to file such report(s) been filed? If the answer is no, identify report(s).
|
x
Yes
No
|
(3)
|
Is it anticipated that any significant change in results of operations from the corresponding period
for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?
|
Yes
x
No
Mediswipe, Inc.
|
(Name of Registrant as Specified in Charter)
|
has caused this notification to be signed on its behalf by the undersigned
hereunto duly authorized.
Date: November 15, 2013
By: /s/ Barry Hollander
Name: Barry Hollander
Title: Chief Financial Officer
Agritek (CE) (USOTC:AGTK)
Historical Stock Chart
From Aug 2024 to Sep 2024
Agritek (CE) (USOTC:AGTK)
Historical Stock Chart
From Sep 2023 to Sep 2024